Key result
Type 1 diabetes in youth is linked to ~0.016 mm thicker carotid bulb intima-media thickness.
Why the study?
Large studies of carotid intima-media thickness in youth with type 1 diabetes were lacking to determine early vascular changes and cardiovascular risk.
Case-Control (n=608)
Mean Difference: 0.016
p-value: p=<0.03
HbA1c may account for early carotid bulb thickening in type 1 diabetes youth; supports glycemic focus but leaves open prospective confirmation of progression.
OBJECTIVE: Type 1 diabetes mellitus causes increased carotid intima-media thickness (IMT) in adults. We evaluated IMT in young subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS: Participants with type 1 diabetes (N = 402) were matched to controls (N = 206) by age, sex, and race or ethnicity. Anthropometric and laboratory values, blood pressure, and IMT were measured. ANCOVA was used to assess differences controlling for demographic risk factors, cardiovascular risk factors, and HbA1c. RESULTS: Subjects were 18.9 ± 3.3 years old (50% male, 82.7% non-Hispanic white). Youth with type 1 diabetes had thicker bulb IMT, which remained significantly different after adjustment for demographics and cardiovascular risk factors. Age, sex, adiposity, and systolic blood pressure were consistent significant determinants of IMT. Adjustment for HbA1c eliminated the difference, suggesting the difference was attributable to poor glycemic control. CONCLUSIONS: Carotid IMT may be increased in youth with type 1 diabetes at high risk for cardiovascular disease. Better control of diabetes may be essential in preventing progression of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Urbina et al. (2013) conducted a case-control in Type 1 diabetes (n=608). Type 1 diabetes vs. Healthy controls was evaluated on Carotid bulb intima-media thickness (MD 0.016 mm, p=<0.03). Youth with type 1 diabetes had a 0.016 mm greater carotid bulb intima-media thickness compared to healthy controls, an effect that was eliminated after adjusting for HbA1c.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: